Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Big pharma stocks near all-time highs as tech selloff pushes investors toward safer bets
Biopharma stocks like AbbVie and Eli Lilly are trading at or near all-time highs, in the latest signal that investors are seeking out the steady gains that come with large, diversified drugmakers. These companies are doing what they do best…
Zydus-Sunshine JV signs pact with Sri Lanka's BOI for $20 mn pharma plant
Published - October 15, 2026 07:11 pm IST - HYDERABAD Subscribe to The Hindu @ Just ₹1* Subscribe to The Hindu @ Just $4.99 *Offer only for new subscribers Zydus Sunshine Lifesciences, a proposed joint venture between Zydus Lifesciences and…
Mankind Pharma to acquire 70% stake in ACTx for €48 million
Mankind Pharma has agreed to acquire a 70% stake in Belgium-based biotechnology company Armed Cell Therapeutics (ACTx) for €48 million, marking its entry into next-generation CAR-T cancer therapies as it looks to expand its research and…
AMGN vs. MRK: Which Pharma Giant's Dividend Actually Has Room to Grow
Should an investor saving for retirement put their next dollar of income capital into Amgen (NASDAQ:AMGN | AMGN Price Prediction) or Merck (NYSE:MRK)? The two yields are near identical. Amgen's annualized forward dividend of $10.08 on a $437.04…
Zydus Sunshine to invest over $20 million in Sri Lanka pharma plant
Zydus Sunshine Lifesciences, a joint venture between Zydus Lifesciences Ltd and Sunshine Healthcare, has signed an agreement with the Board of Investment of Sri Lanka to set up a pharmaceutical manufacturing facility in the island nation, according…
Agility, Access And Scale: 3 Factors Defining Biotech's Future
Brian O'Shaughnessy is Chief Commercial Officer at Uniphar. As one of the leading genetic causes of infant mortality, spinal muscular atrophy (SMA) is a devastating neuromuscular disease that progressively strips young children of the ability to…
Nuvectis Pharma (NASDAQ:NVCT) Stock Jumps 7.7% - What's Next?
Nuvectis Pharma, Inc. (NASDAQ:NVCT - Get Free Report) shares shot up 7.7% on Thursday. The company traded as high as $18.96 and last traded at $19.3850. 19,774 shares traded hands during mid-day trading, a decline of 89% from the average daily…
Ascendis Pharma A/S $ASND Shares Newly Purchased by Avior Wealth Management LLC
Avior Wealth Management LLC bought a new position in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund bought 5,236 shares of the biotechnology company's…
IT Stocks Gain Rs 25,029 Crore
Pharma stocks lost Rs 25,169 crore. India's information technology (IT) stocks added Rs 25,029 crore in market value on Wednesday, October 14, 2026, almost exactly matching the loss suffered by the pharmaceutical (pharma) sector, as investors…
Siemens Switzerland to build new headquarters in Zurich
The Siemens site covers an area of 30,500 square metres and comprises around 35,900 square metres of space, as Procimmo announced on Thursday. The parties have agreed not to disclose the purchase price, as a Siemens spokesperson explained in…
Zurich prosecutor charges journalist over Vincenz revelations
‘Switzerland is a partial member of the EU,' says historian Read more: ‘Switzerland is a partial member of the EU,' says historian Rising inequality, diesel deal and another execution Read more: Rising inequality, diesel deal and…
Japan's Nikkei slumps 5 percent as tech stocks hammered by AI, rate hike worries
Japan's Nikkei share average tumbled nearly 5 percent on Thursday, with tech stocks hit hard by media reports about distressed debt at US cloud-computing provider CoreWeave, while hot US inflation figures sparked fears of higher interest rates.
Sensex fell 252 points and more shares went up than down
The Sensex fell 252 points on Wednesday to 72,781.89, with the Nifty down 99.25 to 22,622.70 — a mild giveback after Tuesday's 1.6 per cent surge. Crude climbing towards 107 dollars did the damage, and IT was the only sector that mattered.
Coursera: Downgraded To Hold Ahead Of Q3 Results, Awaiting Merger Progress (NYSE:COUR)
Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…
AriBio, Fosun, And Alzheimer's Disease: Close, But Perhaps Not Enough (OTCMKTS:SFOSF)
AriBio is nearing phase 3 results for AR1001, a phosphodiesterase-5 inhibitor that limits peroxynitrite-mediated damage in Alzheimer's disease. Shanghai Fosun Pharmaceuticals (SFOSF) secured regional rights to AR1001 via a $60M option fee, with up…
Receive a Daily briefing on Pharma Industry News
Get Started